Karsten Lindhardt
Amministratore Delegato presso Biograil ApS
Profilo
Karsten Lindhardt is the founder and CEO of Biograil ApS, founded in 2019.
He was also the founder of Scantox A.
He previously worked as a Project Director at Prosidion Ltd., a Clinical Pharmacologist at Novo Nordisk A and Ferring Pharmaceuticals A, Vice President-Research & Development at Zyla Life Sciences LLC from 2008 to 2013, SVP & Head-Research & Development at Egalet Ltd., and Manager-Senior Clinical Projects at Curalogic AS.
Dr. Lindhardt holds a graduate and doctorate degree from Danmarks Farmaceutiske Universitet.
Posizioni attive di Karsten Lindhardt
| Società | Posizione | Inizio |
|---|---|---|
Biograil ApS
 Biograil ApS Pharmaceuticals: MajorHealth Technology Biograil ApS is a pre-clinical stage pharmaceutical company. The company was founded by Karsten Lindhardt and Nikolaj Skak in 2019 and is headquartered in Hedehusene, Denmark. | Amministratore Delegato | 01/01/2019 |
Scantox A/S
 Scantox A/S BiotechnologyHealth Technology Scantox A/S offers research services specializing in pharmacological and toxicological areas. It serves pharmaceutical, medical devices, food and agricultural, and chemical industries. The company was founded on September 14, 1977 and is headquartered in Lille Skensved, Denmark. | Fondatore | - |
Precedenti posizioni note di Karsten Lindhardt
| Società | Posizione | Fine |
|---|---|---|
| ZYLA LIFE SCIENCES | Direttore Tecnico/Scientifico/R&S | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
Prosidion Ltd.
 Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Corporate Officer/Principal | - |
Curalogic AS
 Curalogic AS Pharmaceuticals: MajorHealth Technology The Group's principal activities is the development of pharmaceuticals for the treatment of allergy. | Corporate Officer/Principal | - |
Formazione di Karsten Lindhardt
| Danmarks Farmaceutiske Universitet | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Aziende private | 7 |
|---|---|
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Health Technology |
Scantox A/S
Scantox A/S BiotechnologyHealth Technology Scantox A/S offers research services specializing in pharmacological and toxicological areas. It serves pharmaceutical, medical devices, food and agricultural, and chemical industries. The company was founded on September 14, 1977 and is headquartered in Lille Skensved, Denmark. | Health Technology |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Health Technology |
Prosidion Ltd.
Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Health Technology |
Curalogic AS
Curalogic AS Pharmaceuticals: MajorHealth Technology The Group's principal activities is the development of pharmaceuticals for the treatment of allergy. | Health Technology |
Biograil ApS
Biograil ApS Pharmaceuticals: MajorHealth Technology Biograil ApS is a pre-clinical stage pharmaceutical company. The company was founded by Karsten Lindhardt and Nikolaj Skak in 2019 and is headquartered in Hedehusene, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Karsten Lindhardt
